Anna V. Karunnaya

Anna V. Karunnaya

Auto-generated profile, based on publicly available information

Anna V. Karunnaya

Pavlov First Saint Petersburg State Medical University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2019 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Closed access
PDF file
VDVladimir Dobronravov
Vladimir Dobronravov
AKA. V. Karunnaya
A. V. Karunnaya
AKA. V. Kazimirchik
A. V. Kazimirchik
ASA. V. Smirnov
A. V. Smirnov
THE AIM: The analysis of clinical and morphological presentations and outcomes of primary systemic vasculitis associated with anti-neutrophil cytoplasmic antibodies (ANCA-V) with dominant kidney involvement; the determination of clinical and morphological parameters associated with prognosis.PATIENTS AND METHODS. Eighty nine patients with morphologically confirmed ANCA-associated kidney vasculitis on standard immunosuppressive therapy (IST) were included in this retrospective study. Clinical, immunological, and histological indices were analyzed at the time of the kidney biopsy, and early in the short-term (3-6 months) and in the long-term follow-up. The following outcomes were evaluated: the achievement of clinical and immunological remission of the disease; eGFR at the end of follow-up, the progression of renal disease (by the composite point: initiation of renal replacement therapy (RRT) or the estimated glomerular filtration rate (eGFR) 50 %); all-cause mortality. The prognostic significance of clinical and morphological parameters was evaluated in multivariable regression models.RESULTS. Most of cases (78 %) were represented by rapidly progressive or acute nephritic syndrome. Mean eGFR was 23 ml/min/1.73 m2. Fifteen percent of patients required acute dialysis. Dominant morphological phenotypes of glomerular lesions were sclerotic (34 %) and mixed (36 %) according to the International Pathology Classification (IPC). Median follow-up was 24 (8; 55) months. Cumulative 5-year and 10-year patient’s survivals and were 92 % and 86 %, respectively. Cumulative 5-year and 10-year renal survivals were 86 % and 68 %, respectively. The cumulative 5-year and 10-year proportions of cases without progression of kidney disease were 80 % and 55 %, respectively. Within 3-6 months of the induction IST 81 % of patients achieved clinical remission (complete (59 %) or partial (22 %)) (CR3-6), while 84 % of patients had immunological remission. Serum creatinine (Pcr) at the time of kidney biopsy was only the factor associated with the risk of renal progression (Expβ=1.73 (95 %CI 1.40-2.14) per 0.1 mmol/l increase). IPC classes and ANCA Renal Risk Score (ARRS) groups as well as other morphological indices of kidney injury had no independent associations with the renal outcomes in Cox models adjusted for Pcr. The independent factors associated with eGFR at the end of follow-up were: CR3-6 (β=0.36±0.08, p<0.001); age (β=-0.34±0.09, p<0.001), Pcr (β=-0.35±0.09, p<0.001) and the global glomerulosclerosis (β=0.28±0.08, p<0.001). CR3-6 (β=0.57±0.10, p<0.001), and the proportion of cellular crescents (β=0.26±0.12, p=0.023) and interstitial inflammation (β=0.27±0.11, p=0.026) were also independently associated with the change of eGFR by the end of follow-up.CONCLUSION. An unfavorable renal prognosis for ANCA-V determined by severe renal dysfunction due to inflammatory and fibrotic alterations of the organ can be significantly improved by adequate therapy with the achievement of higher patient’s and kidney’s survival. The baseline serum creatinine is only the factor associated with the long-term risks of dialysis and kidney disease progression. In addition to baseline serum creatinine and the development of early clinical remission, the separate assessment of global glomerular sclerosis, cellular crescents, and interstitial inflammation may be more useful for the individual prediction of long-term eGFR changes than IPC classes or ARRS.

15 July 2025 in Nephrology and Dialysis
Verified
Journal Article
Open access
PDF file
NBNikolay Bulanov
Nikolay Bulanov
Elena ZakharovaElena Zakharova
Elena Zakharova
NKN. L. Kozlovskaya
N. L. Kozlovskaya
AVA. V. Vatazin
A. V. Vatazin
AKA. V. Karunnaya
A. V. Karunnaya
VDVladimir Dobronravov
Vladimir Dobronravov
Проект инициативных клинических рекомендаций по диагностике и лечению поражения почек при АНЦА-ассоциированных васкулитах

13 August 2024 in Nephrology and Dialysis
Verified
Journal Article
Open access
PDF file
Elena ZakharovaElena Zakharova
Elena Zakharova
NKN. L. Kozlovskaya
N. L. Kozlovskaya
YKY. V. Korotchaeva
Y. V. Korotchaeva
IBI. N. Bobkova
I. N. Bobkova
VDVladimir Dobronravov
Vladimir Dobronravov
AKA. V. Karunnaya
A. V. Karunnaya
Проект клинических рекомендаций по диагностике и лечению волчаночного нефрита

18 November 2021 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Closed access
PDF file
VDVladimir Dobronravov
Vladimir Dobronravov
AKA. V. Karunnaya
A. V. Karunnaya
INTRODUCTION. СЗ-glomerulopathy (СЗ-GP) is a spectrum of diseases caused by dysregulation of the alternative complement pathway. The present study was carried out taking into account the limited number of foreign and the absence of original studies in the Russian population.THE AIM. Analysis of clinical and morphological manifestations of СЗ-GP at the time of primary diagnosis.PATIENTS AND METHODS. Retrospective analysis of the etiology, clinical data and morphology of СЗ-GP identified in the period 2006-2021.RESULTS. The study included 60 cases. The average age of patients is 4З±17 years. Nephrotic syndrome was detected in 47 % of patients; in 58 % of cases the estimated glomerular filtration rate was <60 ml/ min/иЗ m2. The dominant morphological pattern was membranoproliferative glomerulonephritis (75% cases). In 2 cases, СЗ-GP debuted with clinical and morphological manifestations of the disease of minimal changes, in which the identification of characteristic electron-dense deposits became obvious when performing a second biopsy. 4 cases had at the onset classical signs of complement-mediated thrombotic microangiopathy (atypical hemolytic uremic syndrome) in combination with C3-GP or its subsequent development.Ultrastructural examination was performed in 40 cases. 8 patients (20%) were diagnosed dense deposit disease, 32 patients - C3-glomerulonephritis. Primary C3-GP was detected in 87 % of patients, secondary - in 13 % (monoclonal gammopathies - 10 %, autoimmune diseases - 3 %).Increased level of antibodies to factor H was detected in 2 of 12 patients who underwent this study. Nucleotide variants of unknown clinical significance in complement genes were detected in 2 out of 6 patients during molecular genetic testing.CONCLUSION. C3-GP is a severe variant of glomerular damage with a heterogeneous etiological structure, which requires the use of ultrastructural and molecular diagnostics, as well as clinical analysis and identification of pathogenetic mechanisms to determine approaches to therapy.

17 July 2021 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Closed access
PDF file
VDVladimir Dobronravov
Vladimir Dobronravov
AKA. V. Karunnaya
A. V. Karunnaya
BACKGROUND. The survival of dialysis patients remains unsatisfactory. A number of observational studies have shown that the conditions of initiation of dialysis can influence long-term outcomes, including mortality.THE AIM. To compare the mortality of patients under predefined conditions of optimal (planned) and suboptimal (unplanned) dialysis initiation.METHODS. Using the MEDLINE and EMBASE databases from inception to June 2020, we conducted a systematic search for studies that examined the overall mortality of patients who met or did not meet the predefined conditions for an “optimal” start of renal replacement therapy (RRT): planned vs. unplanned onset; initiation of substitution therapy on permanent access vs. temporary; with priorobservation of the nephrologist vs. without it. As a result of a systematic search, subsequent analysis and selection of publica tions, 8 studies were included in the meta-analysis (total number of incident patients was 22755; 13680 patients met the conditions of the optimal dialysis start).RESULTS. All-cause mortality among patients with the conditions of suboptimal dialysis start was higher than in those with the optimal start (34.4 % vs. 46.6 %, p<0,001) with the increase in the relative risk (RR) of fatal outcome by 35.1 % (95 % confidence interval (CI) 30.8 %-39.4 %, p<0.0001). Estimated number of patients needed to start dialysis in the optimal conditions to prevent 1 death was 8 (95 % CI 7-9).CONCLUSION. The meta-analysis demonstrated the relationship between the urgent initiation of RRT, the use of temporary access for dialysis, and the lack of timely prior follow-up by a nephrologist with an increase in mortality. Prevention of dialysis initiation in these suboptimal conditions in real-world clinical practice can be an effective tool for improving patient-centered outcomes.

25 November 2020 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Closed access
PDF file
VDVladimir Dobronravov
Vladimir Dobronravov
AKA. V. Karunnaya
A. V. Karunnaya
VSV. G. Sipovskii
V. G. Sipovskii
Клинико-морфологическая презентация люпус-нефрита (одноцентровое исследование 157 случаев)